feed,title,long_url,short_url
SeekingAlpha,Omeros: Still Worth A Look Despite Narsoplimab Woes,https://seekingalpha.com/article/4670085,
SeekingAlpha,GMO Q1 2024 Quarterly Letter,https://seekingalpha.com/article/4670097,
